Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

Published:2009-05 Issue:5 Volume:10 Page:489-500
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Ciceri Fabio,Bonini Chiara,Stanghellini Maria Teresa Lupo,Bondanza Attilio,Traversari Catia,Salomoni Monica,Turchetto Lucia,Colombi Scialini,Bernardi Massimo,Peccatori Jacopo,Pescarollo Alessandra,Servida Paolo,Magnani Zulma,Perna Serena K,Valtolina Veronica,Crippa Fulvio,Callegaro Luciano,Spoldi Elena,Crocchiolo Roberto,Fleischhauer Katharina,Ponzoni Maurilio,Vago Luca,Rossini Silvano,Santoro Armando,Todisco Elisabetta,Apperley Jane,Olavarria Eduardo,Slavin Shimon,Weissinger Eva M,Ganser Arnold,Stadler Michael,Yannaki Evangelia,Fassas Athanasios,Anagnostopoulos Achilles,Bregni Marco,Stampino Corrado Gallo,Bruzzi Paolo,Bordignon Claudio

Publisher

Elsevier BV

Subject

Oncology

Reference42 articles.

1. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe;Ljungman;Bone Marrow Transplant,2006

2. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia;Rocha;N Engl J Med,2004

3. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype;Aversa;N Engl J Med,1998

4. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse;Aversa;J Clin Oncol,2005

5. A survey of fully-haploidentical hematopoietic stem cells transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients transplanted in remission;Ciceri;Blood,2008

Cited by 428 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers;Cytotherapy;2024-08

2. iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine;BioEssays;2024-06-25

3. Advances in CAR-T-cell therapy in T-cell malignancies;Journal of Hematology & Oncology;2024-06-24

4. Engineering strategies to mitigate toxicities associated with CAR‐T cell therapy;BMEMat;2024-06-22

5. Fate control engagement augments NK cell responses in LV/hu-IL-12 transduced sarcoma;Experimental and Molecular Pathology;2024-06